APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zika Virus Testing

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Selected research

Market Outlook & Growth Opportunities

Global Zika Virus Testing Market Outlook and Growth Opportunities 2026

Report ID 17389576041 January 2026199 pages

Choose your research edition.

Industry ResearchZika Virus Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Virus Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Zika Virus Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Virus Testing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Virus Testing Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.

This report provides an overview of the global Zika Virus Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Zika Virus Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zika Virus Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Zika Virus Testing market.

Zika Virus Testing Segment by Company

Chembio

Quest Diagnostics

ARUP Laboratories

Luminex

Simens

Abbott Molecular

Hologic

ELITech Molecular Diagnostics

EUROIMMUN US

Creative Diagnostics

Vela Diagnostics

InBios International

Primerdesign

Altona Diagnostics

Zika Virus Testing Segment by Type

Molecular Test

Serologic Test

Zika Virus Testing Segment by Application

Diagnostic Centers

Hospitals

Pathology Labs

Zika Virus Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Zika Virus Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Zika Virus Testing key companies, revenue, market share, and recent developments.

3. To split the Zika Virus Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Zika Virus Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zika Virus Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Zika Virus Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zika Virus Testing industry.

Chapter 3: Detailed analysis of Zika Virus Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Zika Virus Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Zika Virus Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zika Virus Testing Industry Trends Table 2. Zika Virus Testing Industry Drivers Table 3. Zika Virus Testing Industry Opportunities and Challenges Table 4. Zika Virus Testing Industry Restraints Table 5. Global Zika Virus Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zika Virus Testing Revenue Share by Company (2021-2026) Table 7. Global Zika Virus Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Zika Virus Testing Key Company Manufacturing Base & Headquarters Table 9. Global Zika Virus Testing Company, Product Type & Application Table 10. Global Zika Virus Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Zika Virus Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Molecular Test Table 15. Significant Companies of Serologic Test Table 16. Global Zika Virus Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Zika Virus Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Zika Virus Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Zika Virus Testing Sales Value Share by Type (2021-2026) Table 20. Global Zika Virus Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diagnostic Centers Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Pathology Labs Table 24. Global Zika Virus Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zika Virus Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Zika Virus Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Zika Virus Testing Sales Value Share by Application (2021-2026) Table 28. Global Zika Virus Testing Sales Value Share by Application (2027-2032) Table 29. Global Zika Virus Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Zika Virus Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Zika Virus Testing Sales Value Share by Region (2021-2026) Table 32. Global Zika Virus Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Zika Virus Testing Sales Value Share by Region (2027-2032) Table 34. Global Zika Virus Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Zika Virus Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Zika Virus Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Zika Virus Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Zika Virus Testing Sales Value Market Share by Country (2027-2032) Table 39. Chembio Company Information Table 40. Chembio Business Overview Table 41. Chembio Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Chembio Zika Virus Testing Product Portfolio Table 43. Chembio Recent Development Table 44. Quest Diagnostics Company Information Table 45. Quest Diagnostics Business Overview Table 46. Quest Diagnostics Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Quest Diagnostics Zika Virus Testing Product Portfolio Table 48. Quest Diagnostics Recent Development Table 49. ARUP Laboratories Company Information Table 50. ARUP Laboratories Business Overview Table 51. ARUP Laboratories Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. ARUP Laboratories Zika Virus Testing Product Portfolio Table 53. ARUP Laboratories Recent Development Table 54. Luminex Company Information Table 55. Luminex Business Overview Table 56. Luminex Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Luminex Zika Virus Testing Product Portfolio Table 58. Luminex Recent Development Table 59. Simens Company Information Table 60. Simens Business Overview Table 61. Simens Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Simens Zika Virus Testing Product Portfolio Table 63. Simens Recent Development Table 64. Abbott Molecular Company Information Table 65. Abbott Molecular Business Overview Table 66. Abbott Molecular Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Molecular Zika Virus Testing Product Portfolio Table 68. Abbott Molecular Recent Development Table 69. Hologic Company Information Table 70. Hologic Business Overview Table 71. Hologic Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hologic Zika Virus Testing Product Portfolio Table 73. Hologic Recent Development Table 74. ELITech Molecular Diagnostics Company Information Table 75. ELITech Molecular Diagnostics Business Overview Table 76. ELITech Molecular Diagnostics Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio Table 78. ELITech Molecular Diagnostics Recent Development Table 79. EUROIMMUN US Company Information Table 80. EUROIMMUN US Business Overview Table 81. EUROIMMUN US Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. EUROIMMUN US Zika Virus Testing Product Portfolio Table 83. EUROIMMUN US Recent Development Table 84. Creative Diagnostics Company Information Table 85. Creative Diagnostics Business Overview Table 86. Creative Diagnostics Zika Virus Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Creative Diagnostics Zika Virus Testing Product Portfolio Table 88. Creative Diagnostics Recent Development Table 89. Vela Diagnostics Company Information Table 90. Vela Diagnostics Business Overview Table 91. Vela Diagnostics Zika Virus Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Vela Diagnostics Zika Virus Testing Product Portfolio Table 93. Vela Diagnostics Recent Development Table 94. InBios International Company Information Table 95. InBios International Business Overview Table 96. InBios International Zika Virus Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. InBios International Zika Virus Testing Product Portfolio Table 98. InBios International Recent Development Table 99. Primerdesign Company Information Table 100. Primerdesign Business Overview Table 101. Primerdesign Zika Virus Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Primerdesign Zika Virus Testing Product Portfolio Table 103. Primerdesign Recent Development Table 104. Altona Diagnostics Company Information Table 105. Altona Diagnostics Business Overview Table 106. Altona Diagnostics Zika Virus Testing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Altona Diagnostics Zika Virus Testing Product Portfolio Table 108. Altona Diagnostics Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Zika Virus Testing Product Image Figure 2. Global Zika Virus Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Virus Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Zika Virus Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Molecular Test Image Figure 8. Serologic Test Image Figure 9. Global Zika Virus Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Zika Virus Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Zika Virus Testing Sales Value Share by Type (2021-2032) Figure 12. Diagnostic Centers Image Figure 13. Hospitals Image Figure 14. Pathology Labs Image Figure 15. Global Zika Virus Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Zika Virus Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Zika Virus Testing Sales Value Share by Application (2021-2032) Figure 18. Global Zika Virus Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Zika Virus Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Zika Virus Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Zika Virus Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Zika Virus Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Zika Virus Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Zika Virus Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Zika Virus Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Zika Virus Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Zika Virus Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Zika Virus Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Zika Virus Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Zika Virus Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Zika Virus Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Zika Virus Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Test
  • Serologic Test
Applications
  • Diagnostic Centers
  • Hospitals
  • Pathology Labs
Companies covered
  • Chembio
  • Quest Diagnostics
  • ARUP Laboratories
  • Luminex
  • Simens
  • Abbott Molecular
  • Hologic
  • ELITech Molecular Diagnostics
  • EUROIMMUN US
  • Creative Diagnostics
  • Vela Diagnostics
  • InBios International
  • Primerdesign
  • Altona Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Zika Virus Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Zika Virus Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Zika Virus Testing Market Dynamics
  1. 2.1 Zika Virus Testing Industry Trends
  2. 2.2 Zika Virus Testing Industry Drivers
  3. 2.3 Zika Virus Testing Industry Opportunities and Challenges
  4. 2.4 Zika Virus Testing Industry Restraints
3 Zika Virus Testing Market by Company
  1. 3.1 Global Zika Virus Testing Company Revenue Ranking in 2025
  2. 3.2 Global Zika Virus Testing Revenue by Company (2021-2026)
  3. 3.3 Global Zika Virus Testing Company Ranking (2024-2026)
  4. 3.4 Global Zika Virus Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Zika Virus Testing Company Product Type and Application
  6. 3.6 Global Zika Virus Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Zika Virus Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Zika Virus Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Zika Virus Testing Market by Type
  1. 4.1 Zika Virus Testing Type Introduction
  2. 4.1.1 Molecular Test
  3. 4.1.2 Serologic Test
  4. 4.2 Global Zika Virus Testing Sales Value by Type
  5. 4.2.1 Global Zika Virus Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zika Virus Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Zika Virus Testing Sales Value Share by Type (2021-2032)
5 Zika Virus Testing Market by Application
  1. 5.1 Zika Virus Testing Application Introduction
  2. 5.1.1 Diagnostic Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Pathology Labs
  5. 5.2 Global Zika Virus Testing Sales Value by Application
  6. 5.2.1 Global Zika Virus Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zika Virus Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Zika Virus Testing Sales Value Share by Application (2021-2032)
6 Zika Virus Testing Regional Value Analysis
  1. 6.1 Global Zika Virus Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zika Virus Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Zika Virus Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Zika Virus Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Zika Virus Testing Sales Value (2021-2032)
  7. 6.3.2 North America Zika Virus Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Zika Virus Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Zika Virus Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Zika Virus Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Zika Virus Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Zika Virus Testing Sales Value (2021-2032)
  16. 6.6.2 South America Zika Virus Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Zika Virus Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Zika Virus Testing Sales Value Share by Country, 2025 VS 2032
7 Zika Virus Testing Country-level Value Analysis
  1. 7.1 Global Zika Virus Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zika Virus Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Zika Virus Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Zika Virus Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Zika Virus Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Zika Virus Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Zika Virus Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Zika Virus Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Zika Virus Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Zika Virus Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Zika Virus Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Zika Virus Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Zika Virus Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Zika Virus Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Zika Virus Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Zika Virus Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Zika Virus Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Zika Virus Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Zika Virus Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Zika Virus Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Zika Virus Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Zika Virus Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Zika Virus Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Zika Virus Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Zika Virus Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Zika Virus Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Zika Virus Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Zika Virus Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Zika Virus Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Zika Virus Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Zika Virus Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Zika Virus Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Zika Virus Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Zika Virus Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chembio
  2. 8.1.1 Chembio Company Information
  3. 8.1.2 Chembio Business Overview
  4. 8.1.3 Chembio Zika Virus Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chembio Zika Virus Testing Product Portfolio
  6. 8.1.5 Chembio Recent Developments
  7. 8.2 Quest Diagnostics
  8. 8.2.1 Quest Diagnostics Company Information
  9. 8.2.2 Quest Diagnostics Business Overview
  10. 8.2.3 Quest Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
  12. 8.2.5 Quest Diagnostics Recent Developments
  13. 8.3 ARUP Laboratories
  14. 8.3.1 ARUP Laboratories Company Information
  15. 8.3.2 ARUP Laboratories Business Overview
  16. 8.3.3 ARUP Laboratories Zika Virus Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
  18. 8.3.5 ARUP Laboratories Recent Developments
  19. 8.4 Luminex
  20. 8.4.1 Luminex Company Information
  21. 8.4.2 Luminex Business Overview
  22. 8.4.3 Luminex Zika Virus Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Luminex Zika Virus Testing Product Portfolio
  24. 8.4.5 Luminex Recent Developments
  25. 8.5 Simens
  26. 8.5.1 Simens Company Information
  27. 8.5.2 Simens Business Overview
  28. 8.5.3 Simens Zika Virus Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Simens Zika Virus Testing Product Portfolio
  30. 8.5.5 Simens Recent Developments
  31. 8.6 Abbott Molecular
  32. 8.6.1 Abbott Molecular Company Information
  33. 8.6.2 Abbott Molecular Business Overview
  34. 8.6.3 Abbott Molecular Zika Virus Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
  36. 8.6.5 Abbott Molecular Recent Developments
  37. 8.7 Hologic
  38. 8.7.1 Hologic Company Information
  39. 8.7.2 Hologic Business Overview
  40. 8.7.3 Hologic Zika Virus Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hologic Zika Virus Testing Product Portfolio
  42. 8.7.5 Hologic Recent Developments
  43. 8.8 ELITech Molecular Diagnostics
  44. 8.8.1 ELITech Molecular Diagnostics Company Information
  45. 8.8.2 ELITech Molecular Diagnostics Business Overview
  46. 8.8.3 ELITech Molecular Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
  48. 8.8.5 ELITech Molecular Diagnostics Recent Developments
  49. 8.9 EUROIMMUN US
  50. 8.9.1 EUROIMMUN US Company Information
  51. 8.9.2 EUROIMMUN US Business Overview
  52. 8.9.3 EUROIMMUN US Zika Virus Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
  54. 8.9.5 EUROIMMUN US Recent Developments
  55. 8.10 Creative Diagnostics
  56. 8.10.1 Creative Diagnostics Company Information
  57. 8.10.2 Creative Diagnostics Business Overview
  58. 8.10.3 Creative Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
  60. 8.10.5 Creative Diagnostics Recent Developments
  61. 8.11 Vela Diagnostics
  62. 8.11.1 Vela Diagnostics Company Information
  63. 8.11.2 Vela Diagnostics Business Overview
  64. 8.11.3 Vela Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
  66. 8.11.5 Vela Diagnostics Recent Developments
  67. 8.12 InBios International
  68. 8.12.1 InBios International Company Information
  69. 8.12.2 InBios International Business Overview
  70. 8.12.3 InBios International Zika Virus Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InBios International Zika Virus Testing Product Portfolio
  72. 8.12.5 InBios International Recent Developments
  73. 8.13 Primerdesign
  74. 8.13.1 Primerdesign Company Information
  75. 8.13.2 Primerdesign Business Overview
  76. 8.13.3 Primerdesign Zika Virus Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Primerdesign Zika Virus Testing Product Portfolio
  78. 8.13.5 Primerdesign Recent Developments
  79. 8.14 Altona Diagnostics
  80. 8.14.1 Altona Diagnostics Company Information
  81. 8.14.2 Altona Diagnostics Business Overview
  82. 8.14.3 Altona Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
  84. 8.14.5 Altona Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst